GLENMARK PHARMACEUTICALS LTD. financial statements, including revenue, expenses, and profit
The total revenue of GLENMARK for the last quarter is 33.88 B INR, and it's 1.35% lower compared to the previous quarter. The net income of Q3 24 is 3.48 B INR.